Evidence map›Paper›PMID 32468677›Full record

ArticleJournal of neuroscience research2022

Retrospectively assessed subjective effects of initial opioid use differ between opioid misusers with opioid use disorder (OUD) and those who never progressed to OUD: Data from a pilot and a replication sample.

Arpana Agrawal, Paul W Jeffries, A Benjamin Srivastava, Vivia V McCutcheon, Michael T Lynskey, Andrew C Heath, Elliot C Nelson

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotype.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Arpana AgrawalDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Paul W JeffriesDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
A Benjamin SrivastavaDivision on Substance Use Disorders, Department of Psychiatry, Columbia University Medical Center/New York State Psychiatric Institute, New York, NY, USA.
Vivia V McCutcheonDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Michael T LynskeyNational Addictions Centre Addictions Department, Institute of Psychiatry, Psychology, and Neuroscience, King's College, London, UK.
Andrew C HeathDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Elliot C NelsonDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-3037-3962
Washington University in St. Louis · USColumbia University Irving Medical Center · USKing's College London · GB

Funding

Translational Clinical Research Fellowship on Substance Use DisordersT32DA007294 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Frances Rudnick Levin, Diana M Martinez · 1993 to 2026
$9.3M
Identifying Genetic Variants Associated with Opioid Overdose MortalityR01DA046436 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA, NELSON, ELLIOT C · 2018 to 2022
$4.8M
NON-DEPENDENT OPIOID MISUSERS AS GWAS CONTROLSR01DA042620 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA, NELSON, ELLIOT C · 2017 to 2021
$3.3M
USING TRANSGENIC MICE TO EXAMINE THE ROLE OF CNIH3 VARIANTS IN OPIOID DEPENDENCER33DA041883 · NIDA · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D, MORON-CONCEPCION, JOSE A · 2018 to 2020
$1.1M
NIDA NIH HHS R01 DA042620NIDA NIH HHS R01 DA046436NIDA NIH HHS R33 DA041883NIDA NIH HHS T32 DA007294
6 · The paper itself

Abstract

Attempts to identify opioid users with increased risk of escalating to opioid use disorder (OUD) have had limited success. Retrospectively assessed subjective effects of initial opioid misuse were compared in a pilot sample of opioid misusers (nonmedical use ≤60 times lifetime) who had never met criteria for OUD (N = 14) and heroin-addicted individuals in treatment for OUD (N = 15). Relative to opioid misusers without a lifetime OUD diagnosis, individuals with OUD reported greater euphoria and other positive emotions, activation, pruritus, and internalizing symptoms. Consistent with these findings, proxy Addiction Research Center Inventory (ARCI) Amphetamine Group, and Morphine Benzedrine Group scale mean item scores were significantly higher in those with OUD. Replication was attempted in opioid misusers with (N = 25) and without OUD (N = 25) who were assessed as part of an ongoing genetic study. We observed similar significant between-group differences in individual subjective effect items and ARCI scale mean item scores in the replication sample. We, thus confirm findings from prior reports that retrospectively assessed subjective responses to initial opioid exposure differ significantly between opioid users who do, and do not, progress to OUD. Our report extends these findings in comparisons limited to opioid misusers. Additional research will be necessary to examine prospectively whether the assessment of subjective effects after initial use has predictive utility in the identification of individuals more likely to progress to OUD.

Indexed as

Analgesics, OpioidOpioid-Related DisordersHumansRetrospective StudiesAnalgesics, Opioidinitial opioid useopioid misusersopioid use disordersubjective effects

Identifiers

PMID32468677
PMCPMC8142810
OpenAlexW3030774159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.